Rare diseases
Investigational molecules
Locations
A study to evaluate the efficacy and safety of rilzabrutinib in adults with active IgG4-related disease
ItalyComparing RO7771950 with a drug combination of tucatinib, trastuzumab, and capecitabine in patients with HER2-positive metastatic or locally advanced breast cancer
ItalyA study to evaluate the efficacy and safety of DYNE-101 in patients with Myotonic Dystrophy Type 1
ItalyA study to evaluate the effectiveness and safety of clemizole hydrochloride as an additional treatment for patients with Lennox-Gastaut syndrome
ItalyA study to evaluate the use of [68Ga]BED003 for imaging colorectal, gastric, pancreatic, breast, and ovarian cancers.
ItalyItalyA study to evaluate the safety and effectiveness of IKT-001 compared to a placebo in adults with pulmonary arterial hypertension.
ItalyA study on the effectiveness of cagrilintide and semaglutide for weight management in children and adolescents with obesity
ItalyA study of sacituzumab tirumotecan and bevacizumab in patients with newly diagnosed advanced ovarian cancer following first-line platinum-based chemotherapy
ItalyA study of daraxonrasib (RMC-6236) compared to observation in patients with resected pancreatic cancer following chemotherapy
ItalyA study of mirikizumab levels in breast milk of breastfeeding women with ulcerative colitis or Crohn's disease
ItalyA study of acalabrutinib and venetoclax for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who have relapsed after initial treatment
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
